Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

118.98
BATS BZX Real-Time Price
As of 1:40pm ET
 -0.99 / -0.83%
Today’s Change
62.88
Today|||52-Week Range
131.95
+40.72%
Year-to-Date
Biotech Bonanza - Second Half Outlook
Jul 28 / Seeking Alpha - Paid Partner Content
3 Biotech Stocks With Big Incoming Catalysts
Jul 25 / MotleyFool.com - Paid Partner Content
3 Unstoppable Stocks to Buy Before the Next Market Crash
Jul 25 / MotleyFool.com - Paid Partner Content
Rising Risk? Here's What You Can Buy
Jul 24 / Seeking Alpha - Paid Partner Content

Today’s Trading

Previous close119.97
Today’s open119.77
Day’s range118.33 - 120.36
Volume11,404
Average volume (3 months)1,519,074
Market cap$21.6B
Data as of 1:40pm ET, 08/06/2020

Growth & Valuation

Earnings growth (last year)+69.46%
Earnings growth (this year)+318.85%
Earnings growth (next 5 years)+51.10%
Revenue growth (last year)+12.63%
P/E ratio188.9
Price/Sales8.98
Price/Book6.89

Competitors

 Today’s
change
Today’s
% change
MRNAModerna Inc-2.34-3.09%
EXASExact Sciences Corp-3.09-3.36%
NBIXNeurocrine Bioscienc...-2.84-2.39%
IMMUImmunomedics Inc-1.30-2.93%
Data as of 1:45pm ET, 08/06/2020

Financials

Next reporting dateOctober 22, 2020
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$1.7B
Annual profit (last year)-$23.8M
Net profit margin-1.41%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
San Rafael, California

Forecasts